Gilead Sciences, Inc.
$GILD
Public valuation for Gilead Sciences, Inc. (GILD). Fair value, signal, and key metrics — no sign-in required.
Current Price
$146.34
58% Overvalued
Fair Value Estimate
$62
🚧
Turnaround
Negative earnings but showing signs of recovery
Analyst Consensus
Target: $157.41
8% higher than current
Key Metrics
Market Cap
$181.5B
Forward P/E
15.2x
Operating Margin
-133.2%
Revenue Growth
6.4%
PEG Ratio
2.53
Get free watchlist alerts
Join the waitlist for valuation updates on $GILD and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.